Profile image of Meaghan M. Phipps, MD

Meaghan M. Phipps, MD


Complication of Liver Disease
Hepatocellular Carcinoma
Liver Disease
Liver Transplant
Liver Transplant Evaluation
Liver Transplantation
Portal Hypertension
Transplant Hepatology


Dr. Meaghan Phipps earned her BS in Behavioral Neuroscience at Lehigh University prior to attending medical school at the University of Maryland School of Medicine. She completed her residency in Internal Medicine at NewYork-Presbyterian Columbia University Irving Medical Center where she also served as a chief resident. She then completed her Gastroenterology fellowship at NYP Columbia and advanced fellowship training in Transplant Hepatology at NYP Columbia/Cornell.

Dr. Phipps’s clinical practice is focused on the care and management of patients with liver disease, including viral hepatitis, autoimmune liver diseases, metabolic dysfunction-associated steatotic liver disease, and alcohol-associated liver disease. As a transplant hepatologist, she specializes in the care of patients before and after liver transplantation. Dr. Phipps has a particular interest in the care for patients with liver cancer and works alongside her colleagues in surgery, oncology, and interventional radiology in Columbia’s multidisciplinary Liver Tumor Program.

In addition to clinical medicine, Dr. Phipps has an interest in medical education and serves as the Associate Program Director for the NYP Columbia/Cornell Transplant Hepatology Fellowship Program.


2022 AASLD Advanced/Transplant Hepatology Award

2015 Leonard M. Hummel Memorial Award for Excellence in Internal Medicine

2014 Alpha Omega Alpha

2014 Gold Humanism Honor Society

2011 Phi Beta Kappa

2011 Biological Sciences Departmental Honors


Hepatocellular carcinoma
Medical Education


Phipps MM, Verna EC, Pereira MR. Long term outcomes of liver grafts from donors with severe acute respiratory syndrome coronavirus 2: Closing the knowledge gap. Transpl Infect Dis. 2023 Oct;25(5):e14143. doi: 10.1111/tid.14143. Epub 2023 Sep 7. PMID: 37675775.

Verna EC, Phipps MM, Halazun KJ, Markovic D, Florman SS, Haydel BM, Ruiz R, Klintmalm G, Lee DD, Taner B, Hoteit MA, Tevar AD, Humar A, Chapman WC, Vachharajani N, Aucejo FN, Melcher ML, Nguyen MH, Nydam TL, Markmann JF, Mobley C, Ghobrial RM, Langnas AN, Carney C, Berumen J, Schnickel GT, Sudan D, Hong JC, Rana A, Jones CM, Fishbein TM, Busuttil RW, Agopian V. Outcomes in Liver Transplant Recipients with Non-Alcoholic Fatty Liver Disease-Related Hepatocellular Carcinoma: Results from the US Multicenter HCC Transplant Consortium. Liver Transpl, 2023 Jan 1;29(1):34-47. doi: 10.1097/LVT.0000000000000007.

Phipps MM, Verna EC. Coronavirus Disease 2019 and Liver Transplantation: Lessons from the First Year of the Pandemic. Liver Transpl. 2021 Sep;27(9):1312-1325. doi: 10.1002/lt.26194.

Nobel YR, Phipps M, Verna EC. COVID-19 and Effect on Liver Transplant. Curr Treat Options Gastroenterol. 2021 Aug 16:1-17. doi: 10.1007/s11938-021-00355-w.

Phipps MM, Barraza LH, LaSota ED, Sobieszczyk ME, Pereira MR, Zheng EX, Fox AN, Zucker J, Verna EC. “Acute Liver Injury in COVID-19: Prevalence and Association with Clinical Outcomes in a Large US Cohort”. Hepatology. 2020. 10.1002/hep.31404. doi:10.1002/hep.31404.

Miller EH, Annavajhala MK, Chong AM, Park H, Nobel YR, Soroush A, Blackett JW, Krigel A, Phipps MM, Freedberg DE, Zucker J, Sano ED, Uhlemann AC, Abrams JA. Oral Microbiome Alterations and SARS-CoV-2 Saliva Viral Load in Patients with COVID-19. Microbiol Spectr. 2021 Oct 31;9(2):e0005521. doi: 10.1128/Spectrum.00055-21.

Blackett JW, Faye AS, Phipps M, Li J, Lebwohl B, Freedberg DE. Prevalence and Risk Factors for Inappropriate Continuation of Proton Pump Inhibitors After Discharge From the Intensive Care Unit. Mayo Clin Proc. 2021 Oct;96(10):2550-2560. doi: 10.1016/j.mayocp.2020.07.038.

Pomenti S, Gandle C, Sbeih H, Phipps M, Livanos A, Guo A, Yeh J, Burney H, Liu H, Dakhoul L, Kettler C, Gawrieh S, deLemos A, Scanga A, Chalasani N, Miller E, Wattacheril J. “Hepatocellular Carcinoma in Hispanic Patients: Trends and Outcomes in a Large United States Cohort”. Hepatology Communications. 2020. 10.1002/hep4.1575.

Nobel YR, Phipps M, Zucker J, Lebwohl B, Wang TC, Sobieszczyk ME, Freedberg DE. “Gastrointestinal Symptoms and COVID-19: Case-Control Study from the United States”. Gastroenterology. 2020. doi: 10.1007/s11938-021-00355-w.

Phipps M, Livanos A, Guo A, Pomenti S, Yeh J, Dakhoul L, Burney H, Kettler C, Liu H, Miller E, Gawrieh S, DeLemos A, Scanga A, Chalasani N, Wattacheril J. "Gender Matters: Characteristics of Hepatocellular Carcinoma in Women from a Large, Multicenter Study in the United States." American Journal of Gastroenterology. 2020 Sep;115(9):1486-1495. doi: 10.14309/ajg.0000000000000643

Phipps M, Wattacheril J. “Non-alcoholic fatty liver disease (NAFLD) in non-obese individuals.”. Frontline Gastroenterology. 2019. doi: 10.1136/flgastro-2018-101119.

Phipps M, Fox AN, Brown RS. “Selection of Candidates and Timing of Liver Transplantation”. In Schiff’s Diseases of the Liver, (12th ed., pp. 1055-1064). 2017. Wiley-Blackwell.